Department of Health Sciences, University of York, Heslington, York, YO10 5DD, UK.
Chin J Integr Med. 2011 Mar;17(3):173-6. doi: 10.1007/s11655-011-0663-9. Epub 2011 Feb 27.
The revision of CONSORT guidelines for reporting blinding in randomised controlled trials is the subject of controversy and criticism. To determine whether the criticism is justified, in this short communication paper we discuss the problems encountered in the methodology of the assessment of blinding, and the reporting of blinding in randomised controlled trials and the standards of reporting on blinding with reference to their usage in clinical trials of acupuncture for chronic pain. To conclude we recommend two simple guidelines: the development of sound clinical protocols that anticipate potential difficulties and reinforce overall internal validity, and secondly. the accurate reporting of the methodologies used to ensure a clear view of blinding procedures.
CONSORT 指南中关于随机对照试验中盲法报告的修订备受争议和批评。为了确定这些批评是否有道理，在这篇简短的交流论文中，我们将讨论在评估盲法的方法学以及随机对照试验中盲法报告以及参照针刺治疗慢性疼痛临床试验中的使用情况报告盲法标准方面遇到的问题。最后，我们建议两条简单的准则：制定合理的临床方案，预见潜在的困难，增强整体内部有效性；其次，准确报告所使用的方法学，以确保对盲法程序有清晰的了解。
